Discover how TP53 mutations in adult leukaemia impact treatment outcomes and potential strategies for improved patient care.

(FocalFinder/iStock/Getty Images Plus) Researchers have identified a previously unknown neurodevelopmental disorder ...

AI algorithms that can identify which patients are most likely to benefit from a drug recently backed for NHS use as a colorectal cancer (CRC) therapy have been developed by scien ...

Unlock the latest liquid biopsy market data. Explore growth drivers, precision oncology shifts, and the tech fueling ...

Researchers assessed the feasibility of using large language models to match cancer patients with certain genetic mutations to appropriate clinical trials.

In this interview, Dr. Michelle Fraser highlights how base editing and AI-designed enzymes are expanding therapeutic ...

Explore the recent advances in fuzzing, including the challenges and opportunities it presents for high-integrity software ...

Key opportunities in the Bardet-Biedl syndrome market include growing awareness and uptake of IMCIVREE, an FDA-approved drug, and the lack of emerging competitors. The US leads in market size compared ...

Explore how advances in accuracy, throughput and cost are making long-read sequencing more accessible at scale.

When Ben Sasse announced last December that he had been diagnosed with Stage 4 pancreatic cancer, he called it a death ...

Scientists have achieved a world first by loading a complete genome onto a quantum computer – a major step towards using ...